
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $456.9M | -- | -- | $0.48 | -- |
08/07/2025 | Q2 | $436.5M | -- | -- | $0.45 | -- |
05/08/2025 | Q1 | $404.1M | $403.2M | $0.29 | $0.36 | -$0.07 |
02/06/2025 | Q4 | $399.8M | $414.3M | $0.71 | $0.30 | $0.41 |
11/19/2024 | Q3 | $432.5M | $435.5M | $0.71 | $0.42 | $0.29 |
08/07/2024 | Q2 | $425.2M | $421.4M | $0.35 | $0.47 | -$0.12 |
05/08/2024 | Q1 | $390.3M | $388.7M | $0.32 | $0.35 | -$0.03 |
02/06/2024 | Q4 | $380.3M | $373.4M | $0.24 | $0.29 | -$0.05 |
11/09/2023 | Q3 | -- | -- | $0.32 | $0.41 | -$0.09 |
08/09/2023 | Q2 | -- | -- | $0.38 | $0.34 | $0.04 |
05/10/2023 | Q1 | -- | -- | $7.11 | $0.20 | $6.91 |
02/07/2023 | Q4 | -- | -- | $0.46 | $0.22 | $0.24 |
11/15/2022 | Q3 | -- | -- | $0.88 | $0.56 | $0.32 |
08/03/2022 | Q2 | -- | -- | $0.55 | $0.59 | -$0.04 |
05/09/2022 | Q1 | -- | -- | $0.45 | $0.50 | -$0.05 |
02/08/2022 | Q4 | -- | -- | $0.48 | $0.45 | $0.03 |
11/03/2021 | Q3 | -- | -- | $0.92 | $0.47 | $0.45 |
08/04/2021 | Q2 | -- | -- | $0.53 | $0.45 | $0.08 |
04/28/2021 | Q1 | -- | -- | $0.37 | $0.37 | $0.00 |
02/03/2021 | Q4 | -- | -- | $0.47 | $0.37 | $0.10 |
10/28/2020 | Q3 | -- | -- | $0.66 | $0.37 | $0.29 |
08/03/2020 | Q2 | -- | -- | $0.32 | $0.24 | $0.08 |
05/06/2020 | Q1 | -- | -- | $0.33 | $0.39 | -$0.06 |
02/03/2020 | Q4 | -- | -- | $0.39 | $0.30 | $0.09 |
11/06/2019 | Q3 | -- | -- | $0.14 | $0.33 | -$0.19 |
07/31/2019 | Q2 | -- | -- | $0.34 | -- | -- |
05/01/2019 | Q1 | -- | -- | $0.33 | -- | -- |
02/06/2019 | Q4 | -- | -- | $0.28 | -- | -- |
11/05/2018 | Q3 | -- | -- | $0.23 | -- | -- |
08/01/2018 | Q2 | -- | -- | $0.33 | -- | -- |
05/02/2018 | Q1 | -- | -- | $0.33 | -- | -- |
02/07/2018 | Q4 | -- | -- | -$0.05 | -- | -- |
11/08/2017 | Q3 | -- | -- | $0.52 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.27 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.35 | -- | -- |
01/26/2017 | Q4 | -- | -- | $0.35 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.32 | -- | -- |
06/30/2016 | Q2 | -- | -- | $0.38 | -- | -- |
03/31/2016 | Q1 | -- | -- | $0.34 | -- | -- |
12/31/2015 | Q4 | -- | -- | $0.33 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.16 | -- | -- |
Valvoline reported $403.2M worth of top line sales in its most recent quarter.
Valvoline announced earnings per share of $0.29 which represents a miss of analyst forecast a $0.36 per share.
Valvoline reported $150.5M that represents $1.17 per share over the last quarter.
Valvoline's earnings are forecast to decrease from $1.61 per share to $1.53 per share next year representing a decrease of -0.42%.
Valvoline's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.